Literature DB >> 8554470

Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease.

M Sabaté1, M Rodríguez, E Méndez, E Enríquez, I González.   

Abstract

OBJECTIVE: The purpose of this study was to determine in Parkinson disease the impact of pulmonary dysfunction on daily living activities (DLA). PATIENTS: Extrapyramidal motor impairment, pulmonary dysfunction, and DLA disabilities were studied in 58 Parkinson patients consecutively enrolled in a rehabilitation service at a university hospital. MAIN OUTCOME MEASURES: Extrapyramidal motor impairments were assessed by the Unified Parkinson's Disease Rating Scale (UPDRS) and the DLA disabilities by the UPDRS, Hoehn-Yahr, and Schwab-England scales. The pulmonary dysfunctions were assessed by spirometry with flow-volume loops, body plethysmography with lung volumes computation, and maximal inspiratory and expiratory static mouth pressures.
RESULTS: Parkinson patients showed important modifications of pulmonary function with a decrease in forced vital capacity, forced expiratory volume in the first minute, and arterial PO2, and an increase in residual volume and total airway resistance (RAW). In addition, they showed a high incidence of airway ventilatory obstructions and restrictive dysfunction. The impact of lung disease on daily living activities in Parkinson disease patients was higher in subjects with restrictive pulmonary dysfunctions (Schwab-England test and turning in bed and adjusting bedclothes, walking, falling, and freezing when walking items of UPDRS) and airway obstructions (handling utensils, dressing and hygiene items of UPDRS).
CONCLUSIONS: Airway obstructions or restrictive pulmonary dysfunctions present a high prevalence in Parkinson disease, contributing as a main factor for DLA dysfunctions. The evaluation and rehabilitation of respiratory disturbances should be systematically included in the management of these patients.

Entities:  

Mesh:

Year:  1996        PMID: 8554470     DOI: 10.1016/s0003-9993(96)90216-6

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  12 in total

1.  Respiratory-swallowing coordination and swallowing safety in patients with Parkinson's disease.

Authors:  Michelle S Troche; Irene Huebner; John C Rosenbek; Michael S Okun; Christine M Sapienza
Journal:  Dysphagia       Date:  2010-07-11       Impact factor: 3.438

Review 2.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

3.  The effects of a simulated fMRI environment on voice intensity in individuals with Parkinson's disease hypophonia and older healthy adults.

Authors:  Jordan L Manes; Ellen Herschel; Katharine Aveni; Kris Tjaden; Todd Parrish; Tanya Simuni; Daniel M Corcos; Angela C Roberts
Journal:  J Commun Disord       Date:  2021-08-31       Impact factor: 2.288

4.  Impact of Age-related Diseases on Pulmonary Function Tests in Older Japanese Adults: A Cross-sectional Pilot Study.

Authors:  Mitsuhiro Matsuo
Journal:  JMA J       Date:  2020-06-19

5.  The coordination of breathing and swallowing in Parkinson's disease.

Authors:  Roxann Diez Gross; Charles W Atwood; Sheryl B Ross; Kimberly A Eichhorn; Joan W Olszewski; Patrick J Doyle
Journal:  Dysphagia       Date:  2007-11-20       Impact factor: 3.438

Review 6.  Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician.

Authors:  Lorenzo Falsetti; Giovanna Viticchi; Vincenzo Zaccone; Nicola Tarquinio; Lorenzo Nobili; Cinzia Nitti; Aldo Salvi; Gianluca Moroncini; Mauro Silvestrini
Journal:  Med Princ Pract       Date:  2021-07-07       Impact factor: 2.132

Review 7.  Research in Parkinson's disease in India: A review.

Authors:  Pratibha Surathi; Ketan Jhunjhunwala; Ravi Yadav; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

8.  Impact of Levodopa in Lung Functions in Patients with Parkinson Disease.

Authors:  Medha Tandon; Faiz M H Ahmad; Subramanian Narayanan; Charu Mohan; Simone Yadav
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383

Review 9.  Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.

Authors:  Santiago Pérez-Lloret; Daniel P Cardinali
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

10.  Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease.

Authors:  Peter A LeWitt; Rajesh Pahwa; Alexander Sedkov; Ann Corbin; Richard Batycky; Harald Murck
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-11-21       Impact factor: 2.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.